An in-depth look to SHINIL PHARMACEUTICAL CO., LTD. operating, investing, and financing activities

012790 free cash flow for Q3 24 is 2.14 B KRW. For 2023, 012790 free cash flow was 2.29 B KRW and operating cash flow was 15.15 B KRW.